Women with Polycystic ovary syndrome (PCOS) experience multiple fertility treatments, a long
treatment duration and a low pregnancy prevalence. This syndrome is frequently accompanied by
overweight and insulin resistance which can mediate the limited response to fertility
treatment. The Endobarrier device was shown to be efficient in weight and glucose lowering.
The aim of this study is to investigate the ability of the Endobarrier device to improve the
outcome of fertility treatments in women with PCOS.